
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
The price of stiripentol is influenced by factors such as specification, dosage, and purchasing channel, typically ranging from hundreds to thousands of yuan. The exact cost should···【more】
Article source:Captain MedicineRelease date:2026-02-27Recommended:224
Mobocertinib is an oral targeted therapy primarily used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with specific genetic mutations. Its ···【more】
Article source:Captain MedicineRelease date:2026-02-26Recommended:150
Mobocertinib is a targeted therapy drug for non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. Its common side effects include diarrhea, rash, stomatitis, na···【more】
Article source:Captain MedicineRelease date:2026-02-26Recommended:177
The current price of Mobocertinib after medical insurance reimbursement in China is influenced by specific circumstances. If you choose the generic version produced in India, the p···【more】
Article source:Captain MedicineRelease date:2026-02-26Recommended:165
The current price of Mobocertinib is influenced by purchasing channels, regional policies, and medical insurance coverage. This medication must be used strictly under the guidance ···【more】
Article source:Captain MedicineRelease date:2026-02-26Recommended:184
The usual recommended dose of sotorasib is 960 mg (8 tablets x 120 mg) once daily, taken on an empty stomach at least 1 hour before or 2 hours after eating. Specific usage must be ···【more】
Article source:Captain MedicineRelease date:2026-02-25Recommended:162
Sotorasib is a targeted therapy for KRAS G12C-mutated non-small cell lung cancer (NSCLC). Its price varies significantly depending on region, specification, purchasing channel, and···【more】
Article source:Captain MedicineRelease date:2026-02-25Recommended:209
Lumykras (generic name: Sotorasib) is a prescription targeted therapy drug for non-small cell lung cancer (NSCLC) that targets a specific gene mutation (KRAS G12C). Its price is in···【more】
Article source:Captain MedicineRelease date:2026-02-25Recommended:187
The price of Sotorasib varies significantly depending on the region, purchasing channel, and specification. For specific prices, please refer to the actual selling prices at hospit···【more】
Article source:Captain MedicineRelease date:2026-02-25Recommended:171
The side effects of Avatrombopag are generally manageable, with most being mild to moderate in severity. However, risk assessment should be based on individual patient conditions a···【more】
Article source:Captain MedicineRelease date:2026-02-24Recommended:167
Avatrombopag is an oral medication used to treat thrombocytopenia (low platelet count) associated with chronic liver disease or chemotherapy. Its common side effects include headac···【more】
Article source:Captain MedicineRelease date:2026-02-24Recommended:150
The price of Avatrombopag varies significantly, typically ranging from a few hundred to several thousand RMB per box. The specific price mainly depends on the version of the drug (···【more】
Article source:Captain MedicineRelease date:2026-02-24Recommended:189
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended:[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended:[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended:[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended:[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended:[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended:[list:visits]2026-15-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643